These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 31719617)

  • 1. Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis.
    Esmeijer K; Dekkers OM; de Fijter JW; Dekker FW; Hoogeveen EK
    Sci Rep; 2019 Nov; 9(1):16632. PubMed ID: 31719617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effectiveness and safety of statins as a class and of specific statins for primary prevention of cardiovascular disease: A systematic review, meta-analysis, and network meta-analysis of randomized trials with 94,283 participants.
    Yebyo HG; Aschmann HE; Kaufmann M; Puhan MA
    Am Heart J; 2019 Apr; 210():18-28. PubMed ID: 30716508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma.
    Zhou YY; Zhu GQ; Wang Y; Zheng JN; Ruan LY; Cheng Z; Hu B; Fu SW; Zheng MH
    Oncotarget; 2016 Apr; 7(16):21753-62. PubMed ID: 26943041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Statins on Kidney Disease Outcomes: A Systematic Review and Meta-analysis.
    Su X; Zhang L; Lv J; Wang J; Hou W; Xie X; Zhang H
    Am J Kidney Dis; 2016 Jun; 67(6):881-92. PubMed ID: 26905361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteinuria and cholesterol reduction are independently associated with less renal function decline in statin-treated patients; a post hoc analysis of the PLANET trials.
    Idzerda NMA; Pena MJ; Parving HH; de Zeeuw D; Heerspink HJL
    Nephrol Dial Transplant; 2019 Oct; 34(10):1699-1706. PubMed ID: 30184238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant].
    Karie S; Launay-Vacher V; Deray G; Isnard-Bagnis C
    Presse Med; 2006 Feb; 35(2 Pt 1):219-29. PubMed ID: 16493350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
    Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
    J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis.
    Minard LV; Corkum A; Sketris I; Fisher J; Zhang Y; Saleh A
    PLoS One; 2016; 11(7):e0158608. PubMed ID: 27434392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statins for improving renal outcomes: a meta-analysis.
    Sandhu S; Wiebe N; Fried LF; Tonelli M
    J Am Soc Nephrol; 2006 Jul; 17(7):2006-16. PubMed ID: 16762986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Statins on Renal Outcome in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.
    Sanguankeo A; Upala S; Cheungpasitporn W; Ungprasert P; Knight EL
    PLoS One; 2015; 10(7):e0132970. PubMed ID: 26151753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of statins on cardiovascular complications in chronic kidney disease patients: A network meta-analysis.
    Hwang SD; Kim K; Kim YJ; Lee SW; Lee JH; Song JH
    Medicine (Baltimore); 2020 May; 99(22):e20061. PubMed ID: 32481375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining Multiple Treatment Comparisons with Personalized Patient Preferences: A Randomized Trial of an Interactive Platform for Statin Treatment Selection.
    Hopkin G; Au A; Collier VJ; Yudkin JS; Basu S; Naci H
    Med Decis Making; 2019 Apr; 39(3):264-277. PubMed ID: 30873906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of long-term treatment with statins for coronary heart disease: A Bayesian network meta-analysis.
    Lu Y; Cheng Z; Zhao Y; Chang X; Chan C; Bai Y; Cheng N
    Atherosclerosis; 2016 Nov; 254():215-227. PubMed ID: 27764723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials.
    Naci H; Brugts J; Ades T
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):390-9. PubMed ID: 23838105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of statin dose, class, and use intensity on primary prevention of cardiovascular mortality: a national T2DM cohort study.
    Yu JM; Chen WM; Shia BC; Wu SY
    Eur J Clin Pharmacol; 2023 May; 79(5):687-700. PubMed ID: 37010535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis.
    Zhang Z; Wu P; Zhang J; Wang S; Zhang G
    Pharmacol Res; 2016 Mar; 105():74-83. PubMed ID: 26776964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of statin therapy on plasma levels of von Willebrand factor antigen. Systematic review and meta-analysis of randomised placebo-controlled trials.
    Sahebkar A; Serban C; Ursoniu S; Mikhailidis DP; Undas A; Lip GY; Bittner V; Ray K; Watts GF; Hovingh GK; Rysz J; Kastelein JJ; Banach M;
    Thromb Haemost; 2016 Mar; 115(3):520-32. PubMed ID: 26632869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
    Lewicki M; Ng I; Schneider AG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010480. PubMed ID: 25758322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?
    Athyros VG; Katsiki N; Karagiannis A; Mikhailidis DP
    Expert Opin Pharmacother; 2015; 16(10):1449-61. PubMed ID: 26037614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.